The Technical AnalystExchange: STO Sector: Healthcare Industry: Medical Devices
Dignitana AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.79% SEK1.505
America/New_York / 17 mai 2024 @ 10:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 121.22 mill |
| EPS: | -0.250 |
| P/E: | -6.02 |
| Earnings Date: | May 22, 2024 |
| SharesOutstanding: | 80.54 mill |
| Avg Daily Volume: | 0.0348 mill |
| RATING 2024-05-17 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -6.02 | sector: PE 19.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.11x |
| Company: PE -6.02 | industry: PE 54.10 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
SEK 1.397 - 1.623 ( +/- 7.48%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SEK1.505 (3.79% ) |
| Volume | 0.0239 mill |
| Avg. Vol. | 0.0348 mill |
| % of Avg. Vol | 68.64 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DIGN.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
DIGN.ST
Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.